Jeisys Medical Inc. (KOSDAQ: 287410)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,900
+20 (0.16%)
Inactive · Last trade price on Oct 18, 2024

Jeisys Medical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
974,739789,504606,355552,979-
Market Cap Growth
23.01%30.20%9.65%--
Enterprise Value
965,846763,032587,297537,636-
Last Close Price
12900.0010490.008520.007770.00-
PE Ratio
35.6432.5523.0143.98-
PS Ratio
5.885.525.206.80-
PB Ratio
8.748.207.5811.60-
P/FCF Ratio
89.2442.9447.2930.87-
P/OCF Ratio
32.1124.1624.0127.24-
EV/Sales Ratio
5.765.335.046.61-
EV/EBITDA Ratio
22.6218.8015.8920.62-
EV/EBIT Ratio
25.3121.0117.3222.78-
EV/FCF Ratio
88.7841.5045.8030.02-
Debt / Equity Ratio
0.620.270.200.260.74
Debt / EBITDA Ratio
1.650.630.440.470.95
Debt / FCF Ratio
6.471.391.270.690.92
Asset Turnover
0.991.101.211.44-
Inventory Turnover
2.082.052.393.02-
Quick Ratio
1.532.721.901.731.69
Current Ratio
2.003.852.802.252.19
Return on Equity (ROE)
27.29%28.50%42.34%42.59%-
Return on Assets (ROA)
14.09%17.43%22.06%26.06%-
Return on Capital (ROIC)
16.20%20.82%27.14%32.96%-
Earnings Yield
2.81%3.14%4.47%2.46%-
FCF Yield
1.12%2.33%2.11%3.24%-
Buyback Yield / Dilution
-0.33%-0.93%0.42%-40.97%-
Total Shareholder Return
-0.33%-0.93%0.42%-40.97%-
Source: S&P Capital IQ. Standard template. Financial Sources.